Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34+CXCR4+cells in patients with type 2 diabetes, Aso, Y, Jojima T, Iijima T, Suzuki K, Terasawa T, Fukushima M, Momobayashi M, Hara K, Takebayashi K, Kasai K, Inukai T., Endocrine, 50(3), 659-664, 2015年12月